New diagnostic possibilities in systemic neonatal infections: Metabolomics

Early Human Development

Volumn 90, Issue SUPPL.1, 2014, Pages

  Dessì, Angelica ^a   Corsello, Giovanni ^b   Stronati, Mauro ^c   Gazzolo, Diego ^d   Caboni, Pierluigi ^e   Carboni, Roberta ^a   Fanos, Vassilios ^a  

^a DEPARTMENT OF RADIOLOGY   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^d C Arrigo Children's Hospital   (Italy)

^e UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Metabolomics; Neonatal infections; Newborn; Sepsis

Indexed keywords

ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN DERIVATIVE; PRESEPSIN; PROCALCITONIN; UNCLASSIFIED DRUG;

ADVERSE OUTCOME; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; HUMAN; INFECTION PREVENTION; METABOLOMICS; NEWBORN INFECTION; NEWBORN MORTALITY; REVIEW; METABOLISM; NEWBORN; SEPSIS;

BIOLOGICAL MARKERS; HUMANS; INFANT, NEWBORN; METABOLOMICS; SEPSIS;

EID: 84897488349     PISSN: 03783782     EISSN: 18726232     Source Type: Journal    
DOI: 10.1016/S0378-3782(14)70007-6     Document Type: Review

References (17)

1. Shane AL, Stoll BJ Recent developments and current issues in the epidemiology, diagnosis, and management of bacterial and fungal neonatal sepsis. Am J Perinatol 2013, 30(2):131-141.
2. Stoll BJ, Hansen N, Fararoff AA, Wright L, Carlo WA Late-onset sepsis in very low birth weight neonates: the experience of the NICHD neonatal research network. Pediatrics 2002, 110:285-291.
3. Tremolada S, Delbue S, Ferrante P Viral infections of the fetus and newborn infant. Pediatr Med Chir 2008, 30(4):177-191.
4. Chirico G, Cortinovis S, Fonte C, Giudici G Bacterial sepsis. J Chemother 2007, 19(2):28-30.
5. Shah BA, Padbury JF Neonatal sepsis: An old problem with new insights. Virulence 2013, 5(1). [Epub ahead of print].
6. Raimondi F, Ferrara T, Maffucci R, Milite P, Del Buono D, Santoro P, et al. Neonatal sepsis: A difficult diagnostic challenge. Clin Biochem 2011, 44(7):463-464.
7. Mussap M, Puxeddu E, Burrai P, Noto A, Cibecchini F, Testa M, et al. Soluble CD14 subtype (sCD14-ST) presepsin in critically ill preterm newborns: preliminary reference ranges. J Matern Fetal Neonatal Med 2012, 25(5):51-53.
8. Mussap M, Antonucci R, Noto A, Fanos V The role of metabolomics in neonatal and pediatric laboratory medicine. Clin Chim Acta 2013, 426:127-138.
9. Lin ZY, Xu PB, Yan SK, Meng HB, Yang GJ, Dai WX, et al. A metabonomic approach to early prognostic evaluation of experimental sepsis by (1)H NMR and pattern recognition. NMR Biomed 2009 Jul, 22(6):601-608.
10. Liu XR, Zheng XF, Ji SZ, Lv YH, Zheng DY, Xia ZF, et al. Metabolomic analysis of thermally injured and/or septic rats. Burns 2010, 36(7):992-998.
11. Schmerler D, Neugebauer S, Ludewig K, Bremer-Streck S, Brunkhorst FM, Kiehntopf M Targeted metabolomics for discrimination of systemic inflammatory disorders in critically ill patients. J Lipid Res 2012, 53(7):1369-1375.
12. Fanos V, Locci E, Noto A, Lazzarotto T, Manzoni P, Atzori L, et al. Urinary metabolomics in newborns infected by human cytomegalovirus: a preliminary investigation. Early Hum Dev 2013, 89(1):S58-S61.
13. Mickiewicz B, Vogel HJ, Wong HR, Winston BW Metabolomics as a novel approach for early diagnosis of pediatric septic shock and its mortality. Am J Respir Crit Care Med 2013, 187(9):967-976.
14. Izquierdo-García JL, Nin N, Ruíz-Cabello J, Rojas Y, de Paula M, López-Cuenca S, et al. A metabolomic approach for diagnosis of experimental sepsis. Intensive Care Med 2011, 37(12):2023-2032.
15. Wallington J, Ning J, Titheradge MA The control of hepatic glycogen metabolism in an in vitro model of sepsis. Mol Cell Biochem 2008, 308:183-192.
16. Atzei A, Atzori L, Moretti C, Barberini L, Noto A, Ottonello G, et al. Metabolomics in paediatric respiratory diseases and bronchiolitis. J Matern Fetal Neonatal Med 2011, 24(2):59-62.
17. Slupsky CM, Rankin KN, Fu H, Chang D, Rowe BH, Charles PG, et al. Pneumococcal pneumonia: potential for diagnosis through a urinary metabolic profile. J Proteome Res 2009, 8(12):5550-5558.